Other
Foreign operations
Vertex Pharmaceuticals Foreign operations remained flat by 0.0% to $0.05 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 3650.0%, from -$0.00 to $0.05.
Analysis
StatementIncome Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2024Feb 13, 2026
How to read this metric
A negative impact suggests the company benefits from lower-tax foreign jurisdictions, while a positive impact suggests higher foreign tax burdens.
Detailed definition
The impact on the effective tax rate caused by the difference between the U.S. statutory tax rate and the tax rates in f...
Peer comparison
Standard disclosure for multinational corporations in their tax rate reconciliation footnote.
Metric ID:
other_effective_income_tax_rate_reconciliation_foreign_i_8552f1Historical Data
2 years
| FY'23 | FY'24 | |
|---|---|---|
| Value | -$0.01 | $0.21 |
| YoY Change | — | >999% |
Range-$0.01 – $0.21
Avg YoY Growth>999%
Median YoY Growth>999%
Foreign operations at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's foreign operations?
- Vertex Pharmaceuticals (VRTX) reported foreign operations of $0.05 in Q4 2024.
- How has Vertex Pharmaceuticals's foreign operations changed year-over-year?
- Vertex Pharmaceuticals's foreign operations increased by 3650.0% year-over-year, from -$0.00 to $0.05.
- What does foreign operations mean?
- The tax rate impact of operating in countries with different tax rates than the U.S.